Cancer Immunology Project Awards

About this scheme

Key information

Career level
Established independent researcher
Research area
Final submission
Committee review
Funding period
Up to 36 months
Funding amount
Up to £300k
Cancer Immunology Project Awards seek to catalyse research and build the UK's research base in cancer immunology, by funding immunologists in non-cancer fields.

Applications are accepted from:

  • Scientists, clinicians or health care workers from UK universities, medical schools, hospitals and some research institutes.
  • The lead applicant (PI) must be an immunologist who should not have a demonstrated track record in cancer research.
  • Collaborations with cancer researchers/clinicians are strongly encouraged to deliver the project but are not a mandatory requirement.
  • Those with a demonstrated track record in cancer and researchers from CRUK core funded Institutes are not eligible to apply for this award as the lead PI, but may act as a co-investigator or collaborator.

The aim of the scheme is to build capacity in cancer immunology; therefore, immunologists who already have a demonstrated track record in cancer research are advised that the Programme Awards from the Science Committee may be more appropriate.

To assess your suitability to apply, please email a one-page summary of your proposal, a list of potential collaborators and your CV to

Research areas:

The Cancer Immunology Awards should address key questions in the immunology of cancer. Applications can be in any area of immunological research, providing the cancer relevance is clearly articulated in the proposal, including any of the following key areas:

  • Cellular and molecular immunology, including but not limited to mechanisms of tolerance; the regulation of immune function, and; the development of memory
  • Inflammation, allergy, transplantation and auto immunity (how the basic understanding of relevant mechanisms involved could drive forward our understanding of cancer)
  • The immune response to infection
  • The interaction of immune cells with tissues
  • Immunity and disease susceptibility/resistance

This award does not support the development of new biotherapeutics or immunomodulatory agents.

Funding support provided for:

  • Salaries for researchers and technical staff
  • Running expenses
  • Equipment

How to apply to this scheme

Application process

Applications for Cancer Immunology Project Awards are considered twice a year. Applications will be assessed by international peer review, before review by the Cancer Immunology Expert Review Panel. The final funding decision will be made 6-8 weeks later by the Science Committee.


  Full application deadline  

    May 2019 Science Committee  

07 November 2018

    October 2019 Science Committee  

04 April 2019


Before you begin your application

The Science Committee will judge your proposal based on:

  • Scientific excellence: all applications must have a strong scientific rationale, as well as appropriate experimental design and statistical analyses, to support the proposed research proposal. 
  • Cancer relevance: value of the proposed work in advancing the fundamental understanding of cancer or improving how cancer is diagnosed and/or treated.
  • Track record: the lead applicant and/or team members should have an excellent track record and potential to produce outstanding results.
  •  Excellent team and collaborative environment: suitability and feasibility of the Lead Applicant(s) (and supporting roles) to carry out the proposed research with access to the resources and facilities required for the successful fulfilment of the Programme Award. The added value of the proposed collaboration and the individual contributions, as well as the steps taken to ensure an effective collaboration.
  • Resources requested: the costs requested in an application should be for the direct costs of the research and be reasonably justified in line with the experimental plans, leveraging existing resources where appropriate. 

The Committee will also consider how your proposed research aligns with our strategic priorities, as set out in our Discovery Research Statement of Intent and our broader Research Strategy.


Applications are assessed by the Cancer Immunology Expert Review Panel. Final funding decisions are made by the Science Committee

Cancer Research UK contact details

You must contact us to discuss your proposal before starting your application.

Maurice Darding

Dr Maurice Darding - Research Funding Manager

Tel: 020 3469 8780


More opportunities for discovery researchers

Discovery Research

We support a broad portfolio of discovery research, including basic biology, genetics and immunology, biomarker discovery and preclinical studies, and engineering and physical sciences applied to cancer. We have a variety of grant funding and other opportunities to accelerate your research.